Delivery Order SPE2DB25D3108-SPE2DB25FPEBZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,996.37 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal hormone replacement therapy product. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a $2,524.95 delivery order to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal estrogen medication used in hormone replacement therapy. This competitively awarded, firm fixed-price contract was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,564.48 delivery order to AmerisourceBergen Drug Corp for Climara Pro Patch 4S on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price contract was competitively awarded without a set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The product being delivered is a transdermal estradiol patch used in hormone replacement therapy, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,090.44 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a hormone replacement therapy product. This non-set-aside, firm fixed price delivery order was competitively awarded on September 2, 2025, with an ultimate completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,009.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal estrogen medication used in hormone replacement therapy. This non-competitive delivery order, issued on September 12, 2025, with a completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,585.86 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal hormone replacement therapy product. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct procurement with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania, the company's headquarters and...
- The Defense Logistics Agency awarded a $1,009.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Climara Pro Patch 4S, a transdermal estrogen medication. This non-set-aside competitive award was issued on May 8, 2025, with an ultimate completion date of May 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,781.69 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Climara Pro Patch 4S, a transdermal hormone replacement therapy patch. This firm fixed-price delivery order, which is not set-aside designated, reflects a competitive award to the vendor and represents a single transaction under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $1,078.12 to AmerisourceBergen Drug Corp for CLIMARA PRO PATCH 4S, a hormone replacement therapy product. This firm fixed-price, non-set-aside contract was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025. The order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,028.18 to AmerisourceBergen Drug Corp for CLIMARA PRO PATCH 4S, a transdermal estradiol patch used for hormone replacement therapy. This firm fixed price delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract involves no set-aside designation, indicating it...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPEBZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,258.26 to AmerisourceBergen Drug Corp for the supply of Climara Pro Patch 4S, a transdermal estradiol hormone replacement therapy product. Issued on September 26, 2025, with an ultimate completion date of September 29, 2025, this firm fixed-price delivery order represents a competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion through December 2026. This prime vendor agreement enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally. The company serves as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare programs, leveraging its extensive pharmaceutical portfolio to fulfill federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/26/25 |